Hollysys to Provide Distributed Control System ProfiBus Technology for Hongshan Power Plant

Hollysys Automation Technologies, Ltd. ("Hollysys" or the "Company"), a leading provider of automation and control technologies and applications in China, announced today that it signed a contract to provide its proprietary Distributed Control System ("DCS") combined process fieldbus communication technology ("ProfiBus") for 2×1GW ultra-supercritical thermal power generating units in Fujian Hongshan Thermal Power Plant (Hongshan Power Plant).

ProfiBus is an universal, open fieldbus which links controllers or control systems with decentralized field devices like sensors and actuators on the field level and enables consistent data exchange with higher ranking communication systems. The consistency of ProfiBus is enabled by utilizing a single, standardized, application-independent communication protocol which supports fieldbus solutions both in factory and process automation. ProfiBus permits the fast communication with intelligent and distributed devices and brings enormous savings resulting from the reduction in cabling and input/output hardware, and can transmit significantly greater amount of information which implies significant cost advantages for plant operation and maintenance.

In this project, Hollysys' DCS will control more than 13,000 points and the ProfiBus will control over 3,600 distributed devices for the two GW level generating units, which will be the largest ProfiBus application in GW level thermal power plant in China. This also marks another milestone for Hollysys in the GW level thermal power plant industry adopting ProfiBus technology together with its high-end DCS.

Dr. Changli Wang, Chairman and CEO of Hollysys, commented, "We are very proud of the contract win to apply our proprietary ProfiBus DCS to the largest scale of thermal power generating units in China, which evidenced our leading technology and capability. Since the end of last year, we restructured our marketing sales force and organized industry professional teams to further penetrate the high-end segments of industrial automation market, and we have gradually seen the fruitful results. Going into the future, we will continue to capture our fair share in the high-end market and intensify our sales efforts in the low to mid-end market to further enhance our market position, and create value for our shareholders."

About Hollysys Automation Technologies, Ltd. (NASDAQ: HOLI)

Hollysys Automation Technologies is a leading provider of automation and control technologies and applications in China that enables its diversified industry and utility customers to improve operating safety, reliability, and efficiency. Founded in 1993, Hollysys has approximately 3,500 employees with nationwide presence in over 60 cities in China, with subsidiaries and offices in Singapore, Malaysia, Dubai, India, and serves over 5,000 customers more than 20,000 projects in the industrial, railway, subway & nuclear industries in China, South-East Asia, and the Middle East. Its proprietary technologies are applied in its industrial automation solution suite including DCS (Distributed Control System), PLC (Programmable Logic Controller), RMIS (Real-time Management Information System), HAMS (HolliAS Asset Management System), OTS (Operator Training System), HolliAS BATCH (Batch Application Package), HolliAS APC Suite (Advanced Process Control Package), SIS (Safety Instrumentation System), high-speed railway signaling system of TCC (Train Control Center), ATP (Automatic Train Protection), Subway Supervisory and Control platform, SCADA (Surveillance Control and Data Acquisition), nuclear conventional island automation and control system and other products.

Source: http://www.hollysys.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.